"Discovery Science"

View all stories
article thumbnail

Your questions answered: How Merck is responding to the COVID-19 pandemic

article thumbnail

Vaccines aren’t virtual

The importance of childhood well visits to prevent certain infectious diseases during the pandemic

article thumbnail

Our new London Discovery Research Center site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

article thumbnail

No patient left behind in our clinical trials

We’re here for patients when they need us most

article thumbnail

If you build it (in 3D), they will come

Innovating with the power of 3D printing

article thumbnail

“Pride and honor”: Meet the Army microbiologist and Merck employee fighting COVID-19

article thumbnail

Merck tackles epidemics and pandemics: an illustrated history

article thumbnail

Merck announces three significant scientific efforts in the fight against COVID-19

article thumbnail

Clinical trials bring our medicines and vaccines to life

We appreciate all who have contributed to our clinical research

article thumbnail

Remembering Arnold Demain, one of our giants

A pioneering research microbiologist for our company leaves behind an impressive legacy.

article thumbnail

Merck joins the World Cancer Day movement to push for progress

Cancer is one of the most significant health challenges of our time – cutting lives too short for far too many people.

article thumbnail

Podcast: How Merck is looking at past epidemics and science to respond to the coronavirus outbreak

article thumbnail

Over 30 Years: The Mectizan® Donation Program

article thumbnail

Merck joins South San Francisco biotech community with innovative research site and hunger for collaboration

article thumbnail

Antimicrobial resistance: a problem without a simple answer

A Point of View by Joan R. Butterton, M.D., associate vice president, clinical research, infectious diseases

article thumbnail

Meet a scientist who helps translate inventions into vaccines to protect public health: Beth-Ann Coller

article thumbnail

Meet two scientists whose goals are to help end the HIV epidemic

article thumbnail

Progress and purpose: a conversation with Merck scientists and HIV care providers

article thumbnail

Merck's commitment to prevention and care for NCDs

Non-communicable diseases (NCDs) — diseases that can’t be transmitted from person to person — are the leading causes of death and disability worldwide.

article thumbnail

Speeding up drug discovery

How Merck chemists are working to find new medicines faster

article thumbnail

Dr. Cathy Pietanza: ‘each day, I’m reminded of my patients’

article thumbnail

The Vaccine Pioneers

article thumbnail

Vaccines: our history, our legacy

Merck and its legacy companies have been working to discover and develop vaccines for more than a century.